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To understand the abilities of Ca-alginate microcapsules and their specific applications in different fields, it is necessary to
determine the physicochemical and structural properties of those formulated microcapsules. In this work, we aimed to study the
effect of alginate concentration in the improvement of the encapsulation efficiency (EE) and on the release of phenolic and
flavonoid substances.*e relationship between the structure of the encapsulated bioactive substance and Ca-alginate network and
their effect on the EE and release kinetics have been investigated. *e incorporation, structure, morphology, and phase properties
of all elaborated materials were characterized by UV-spectroscopy, Fourier transform infrared (ATR-FTIR), scanning electron
microscope (SEM), and X-ray diffraction (DRX). *e results indicate that increasing the polymer concentration increases the EE
and decreases the loading capacity (LC), whereas the effect of alginate polymer concentration on the release was not observed.*e
release study of bioactive substances showed that the release kinetics is relatively dependent on the structure and the physi-
cochemical characteristics of the bioactive substance, which became clear when the encapsulated compounds were released from
the core of calcium alginate microcapsules. *us, it could be concluded that the pores size of the Ca-alginate network is smaller
than the volume of the crocin molecule (2794.926 Å3) and higher than the volume of the gallic acid molecule (527.659 Å3). For the
same microcapsules system, the release mechanism is affected by the structure and physicochemical properties of the
encapsulated molecules.
1. Introduction
Microencapsulation technology aims to protect bioactive
substances, during processing, improving stability from
external harsh conditions in final products and during
processing, masking undesirable odors and tastes of in-
gredients, and the delivery of the encapsulated matter at
controlled rates, at a certain time, and in a certain place
[1, 2]. *e choice of shell material is an important step in
order to encapsulate a bioactive substance. Generally, the
mechanical and physicochemical characteristics of a mi-
crocapsule are directly linked to the shell structure which is
easily affected by the structure and the thickness of the wall
material, the chemical composition, and the size of the
microcapsule [1, 3].
Alginate acid extracted from brown algae is a natural
biopolysaccharide which has many advantages compared to
commonly used biopolymers for hydrogel beads
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formulation [4–6]. *e mannuronic acid (M-block),
guluronic acid (G-block), and mixed sequences of M-G-
blocks are the main chains that constitute the alginate
polymer.*e sequence and ratio (M/G) of these uronic acids
vary with the origin of alginate and control their properties
[7]. A broad range of application can be found in food and
pharmaceutical industries due to the biocompatibility,
biodegradability, and nontoxicity of this biomaterial and
also to their gelling properties when it crosslinked with
divalent ions such as calcium and ferrous cation [3, 8–10].
Sodium alginate polymer, obtained from brown algae, has a
number of features that makes it particularly appropriate to
form hydrogel microcapsules, such as its low cost, high
availability, biodegradability, biocompatibility with other
agents, and easy synthesis of microparticles [3, 8, 11, 12].
*e application area of alginate microcapsules is mainly
depending on the properties presented by those micro-
capsules, which make it necessary to determine their
physicochemical, mechanical, and structural properties.
Alginate microcapsules are largely applied in the pharma-
ceutical industries, as an example, due to their ability to
release the bioactive substance through the diffusion
mechanism. On the other hand, another important me-
chanical property is the release rate, which is mainly related
to the porosity of the microcapsules. *e release of the
encapsulated substance in different applications is mostly
due to the diffusion mechanism, as a principal process in
controlled release systems. *e diffusion mechanism can be
shortened into the transport of bioactive substance from the
internal core to the external microcapsule shell [13–17].
During the release, the microcapsule matrix might re-
main unchanged, but in some cases, the change can occur
due to the swelling behavior, shrinking, or fragmentation
phenomena. Other factors can control the release of bio-
active substance beside the structural properties of the
microcapsules, such as the structure of those bioactive
compounds and the physicochemical properties of the en-
capsulating material like their solubility degree in the mi-
crocapsules internal core, rheological properties presented
by the substance inside the polymer capsule, the pore size of
biopolymermicrocapsules, the potential interaction between
the microcapsule network and the encapsulated substance
microcapsules properties (such as shape, size, and structure),
and the concentration gradient of bioactive substance be-
tween the microcapsules wall and its surrounding envi-
ronment [13–18]. *e relative importance of those different
parameters depends on the composition and internal
structure of the elaborated microparticles.
In our previously reported work [3] on the mechanical
properties of calcium alginate microcapsules, the increase of
sodium alginate concentration led to the improvement of the
mechanical strength of microcapsules. In the present study,
we mainly focused on the properties of microcapsules
elaborated with different sodium alginate concentrations
foreseeing the encapsulation and controlled release of bio-
active phenolic and flavonoid substances such as gallic acid
and crocin as bioactive substances which have different
structures and physicochemical characteristics. In addition,
to better understand the relationship between the structure
of encapsulated bioactive substances and the structure of
microcapsules network, the effect of sodium alginate con-
centration and the structure of bioactive substances on the
encapsulation efficiency, loading capacity, and the release
was also examined.
2. Materials and Methods
2.1.Materials. In this study, a medium viscosity (5–40 cps of
1% aqueous solution) sodium alginate, with a molecular
weight of 22500 g/mol, purchased from Sigma-Aldrich Co.
(St. Louis, USA) was used.
Crocin, gallic acid monohydrate (≥99%), calcium
chloride dihydrate, and trisodium citrate were obtained
from Sigma-Aldrich Co. (St. Louis, USA) and used without
any further purification.
*e conductivity of the distilled water used for all sample
preparation was less than 2 µS.
2.2. Preparing Calcium Alginate Microcapsules. Calcium
alginate microcapsules containing bioactive substances were
prepared using the ionotropic gelation method under op-
timal formulation as described previously in our works [8].
Briefly, 3–6% (w/v) of the sodium alginate and 1.5% (w/v) of
bioactive substance were dissolved in 100ml of distilled
water. Hydration of samples was assured using magnetic
stirring. After full hydration using amagnetic stirring, the air
bubbles formed during the mixing were removed from the
aqueous medium by allowing the solution to stand for two
hours. *e mixed solution was left to stand for about two
hours to remove air bubbles from the aqueous medium. *e
gelling-bath solution was prepared by dissolving CaCl2 in
distilled water 4% (w/v). A pump was applied to control the
delivery of the mixed solution of sodium alginate and
bioactive substance through a tube which was connected
with a polypropylene micropipette tip, and the mixture
solution falls into the CaCl2 solution continuously, as shown
in Figure 1.
2.3. Bioactive Substances Characteristics. *e characteristics
and the geometry optimization of bioactive substances were
carried out using MOPAC package, module version 2016,
and the calculation was performed with the RM1 semi-
empirical method.
2.4. Bioactive Substance Content Measurement and Loading
Efficiency. *e amount of BS was determined by the direct
measurement of the absorbance using the UV-visible
spectrophotometer at 265 nm for GA and 440 nm for crocin.
(i) For the gallic acid, the concentration was obtained
through a calibration curve using GA as the standard
reference, under identical experimental conditions
(ii) For the crocin agent, the concentration was obtained
through a calibration curve using crocin as the
standard reference, under the similar experimental
conditions
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Loading capacity was calculated using the following
formula:
loading capacity �
weight of bioactive agent in the calcium alginate microbeads
weight of dried calcium alginate microbeads
× 100. (1)
*e encapsulation efficiency was calculated using the
following formula:
encapsulation efficiency �
amount of bioactive agent in the beads
original amount of bioactive agent
× 100. (2)
2.5. Attenuated Total Reflection Fourier Transform Infrared
(ATR-FTIR) Analysis. *e interactions between calcium
alginate microcapsule and the encapsulated bioactive sub-
stance have been studied using the ATR-FTIR technique.
*e spectrums were carried out on a Jasco4700-ATR
spectrophotometer (Shimadzu, Japan), in the wavelength
region between 400 and 4000 cm−1. *e obtained spectra for
each sample were affected by averaging 32 scans at a res-
olution of 4 cm−1.
2.6. Morphological Characterization. *e external structure
of the obtained calcium alginate microcapsules was evalu-
ated using a scanning electron microscope (FEI ESEM
“Quanta 200,” USA). *e scanned micrographs were col-
lected digitally by ETD software.
2.7. X-Ray Analysis. To investigate the physical form
(amorphous or crystalline) of the blank and gallic acid
loaded microcapsules, X-ray analysis were performed. *e
X-ray diffraction patterns were acquired on a Shimadzu
XRD-6000 (Shimadzu, Japan), using the CuKα radiation.
*e patterns were collected in 2θ range of 2°–80° with a step
size of 0.02°.
2.8. GA Release Study. *e release of bioactive substances
from the elaborated microparticles in an aqueous medium
was achieved using the UV-visible spectrophotometer. *e
analysis was realized based on our previously described
method [8]. Briefly, a known amount of microcapsules was
suspended in 100ml of distilled water. *e samples un-
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Figure 1: Simple schematic illustration for the preparation of bioactive substances loaded in Ca-alginate microcapsules.
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magnetic stirrer (Variomag Poly 15, Germany) operating at
250 rpm. An aliquot of the supernatant was taken at pre-
determined time intervals for absorbance measurement at
265 and 440 nm, respectively, for gallic acid and crocin, and
the released bioactive substances amount was obtained by
using concentration versus absorbance calibration curves.
Finally, 30ml of a sodium citrate solution (2%, w/v) was
added, and final absorbance was recorded and corrected by
considering the dilution.
2.9. Analysis of Kinetics Release Data. Zero-order, first-or-
der, and Korsmeyer–Peppas mathematical models were
carried out to evaluate the kinetic release behavior of the
encapsulated compounds from alginate microcapsule in the
interest to predict and correlate their release [19, 20].
Zero-order model is
Q � k0t + Q0. (3)
Q in the model equation represents the amount of the
active compound released as function of time t (min),




Q in the model equation represents the amount of the
active compound released as function of time t (min),





Q in the model equation represents the amount of the
active compound released as function of time t (min),
kp is a rate constant, and n is the diffusional exponent,
indicative of the encapsulated compound release
mechanism.
In this mathematical study, the Korsmeyer–Peppas
model was used with the aim to determine the release
mechanism of the encapsulated compound between three
expected mechanisms, Fickian release (diffusion-controlled
release), non-Fickian release (anomalous transport), and
case II transport (relaxation-controlled release) [20, 21].
*e Korsmeyer–Peppas model was particularly estab-
lished in order to study the release mechanism of substance
encapsulated on a polymeric matrix [20], which is the case in
this study. *e use of the Korsmeyer–Peppas model requires
the determination of exponent n; accordingly, it is suggested
to use only the first 60% of the substance release data. *e n
value determined generally used to distinguish between the
three mechanisms issued previously, in which Fickian re-
lease is verified at the n value less than 0.43, while the non-
Fickian release mechanism is established where the n value is
between 0.43 and 0.85, although the n value higher than 0.85
indicates the case II transport release [20–22]. Using Ori-
ginPro 2018 software, the calculation of the squared cor-
relation coefficient (R2) was used to confirm the accuracy of
those models.
3. Results and Discussion
3.1. Bioactive Substances Characteristics. *e calculated
ground state geometries of gallic acid and crocin molecules
are illustrated in Figure 2. *e crocin molecule has a
branched and flexible structure due to the conjugated system
elongated along the entire polyene chain, whereas the
molecule of gallic acid has a well-defined structure.
*e obtained physical-chemical characteristics of gallic
and crocin bioactive molecules (Table 1) show that crocin is
freely soluble in water, while the solubility of gallic acid is
limited (11.9 g/l), and the polarizability of crocin molecule is
higher than of the molecule of gallic acid. In addition, the
crocin molecule has a higher topological polar surface area
andmolecular volume comparedwith the gallic acidmolecule,
which allows us to discuss the porosity of our delivery system.
3.2. Bioactive Substance Content Measurement and Loading
Efficiency. *e obtained encapsulation efficiency (EE) and
loading capacity (LC) for all elaborated formulations are
presented in Table 2. Considering the applied encapsulation
method, the used polymer, the low molecular weight, gallic
acid solubility in water, and therefore the high solubility of
crocin in water, the LC and EE values were satisfying.
Moreover, and as shown within the release study, a crucial
amount of the encapsulated bioactive substance was released
within the primary 20 minutes for gallic acid, and within the
50 minutes for crocin, which suggests that in the preparing
process, bioactive substance could release into the solution
and, consequently, may limit the loading efficiency. Similar
results were reported [6, 8, 23, 24]. *e results also show that
increasing the alginate polymer concentration causes a rise
of encapsulation efficiency and a decrease of the loading
capacity. *is verifies our hypothesis that suggests that the
increase of the sodium alginate concentration can certainly
lead to introduce a higher level of Ca2+ ions responsible of
the cross-linking between the alginate chains and, conse-
quently, forms a dense cohesive structure (heavy micro-
capsules). *e structural properties of the crocin molecule
are responsible for the enhancement of EE and LC compared
with the encapsulation efficiency and loading capacity of
gallic acid (Table 2).
3.3. Attenuated Total Reflection Fourier Transform Infrared
(ATR-FTIR)Analysis. ATR-FTIR spectra of sodium alginate
polymer, gallic acid, blank calcium alginate microcapsules,
calcium alginate microcapsules loaded gallic acid (Alg-3%),
calcium alginate microcapsules loaded gallic acid (Alg-4%),
calcium alginate microcapsules loaded gallic acid (Alg-5%),
and calcium alginate microcapsules loaded gallic acid (Alg-
6%) are presented in Figure 3.
*e spectrum of gallic acid shows two bands at
3268 cm−1 and 3491 cm−1 attributed to the O-H function and
two other bands situated at 1605 cm−1 and 1307 cm−1
characterize the C�O group. Furthermore, the peak at
1021.12 cm−1 with relatively high intensity was assigned to
the benzene ring vibration (Figure 3(a)) [6, 25]. In the case of
sodium alginate polymer, the spectrum reveals the presence
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of a broad vibrational band located at 3268 cm−1, which is
attributed to the stretching of the O-H function. *e
symmetrical and asymmetrical stretching vibrations of
COO− groups were observed at 1593.88 cm−1 and
1405.85 cm−1, respectively (Figure 3(b)) [6, 26–29].
On the other hand, the spectrum of the blank calcium
alginate microcapsules shows a broad peak at 3342 cm−1
assigned to H2O molecules. Additionally, for the two peaks
of COO− groups, a remarked shift toward higher wave-
number was observed (1598 cm−1 and 1435 cm−1 for the
symmetrical and asymmetrical vibrations, respectively),
suggesting that Ca2+ crosslinked the COO− groups of the
alginate (Figure 3(c)).
In the case of calcium alginate microcapsules loaded with
gallic acid (Figures 3(d)–3(g)), the spectrum indicates a shift
of all characteristic peaks to higher wavenumbers without
observing any new peaks in comparison with the spectrum
of blank calcium alginate microcapsules, thus indicating the
incorporation with a possible interaction of gallic acid with
the microcapsules as reported in numerous previous studies
[6, 8, 30]. In addition, as stated in several reports, gallic acid
tends to autoxidize, when electrospinning zein fibers loaded
with gallic acid, to dimer or oligomer structure [8, 31, 32]. By
using a similar method, our examination illustrates the
significant stability of gallic acid in the obtained calcium
alginate microcapsules.
Figure 4 represents the ATR-FTIR spectra of crocin,
sodium alginate polymer, blank calcium alginate micro-
capsules, calcium alginate microcapsules loaded crocin (Alg-
3%), calcium alginate microcapsules loaded crocin (Alg-4%),
calcium alginate microcapsules loaded crocin (Alg-5%), and
calcium alginate microcapsules loaded crocin (Alg-6%).
*e ATR-FTIR spectrum of crocin shows a centered
peak at 3301 cm−1 corresponding to hydrogen bonds of the
O-H of alcoholic groups. Moreover, the band located at
1694 cm−1 represents the C�O stretching vibration, and the
intense vibrational band at 1014 cm−1 is attributed to the
C-O stretching vibration (Figure 4(a)) [23, 33].
After elaboration of calcium alginate microcapsules
loaded with crocin, it is observed that the characteristic
bands were shifted to higher wavenumber (Figures 4(d)–
4(g)) compared to the spectrum of blank calcium alginate
microcapsules (Figure 4(c)) without observing any new
peaks, which indicates the stability of microcapsule caused
by the incorporation with a possible interaction between
crocin and calcium alginate microcapsules [23].










Phenolic substance Gallic acid 11.9 12.040 170.12 98 527.659
Flavonoid substance Crocin Freely soluble 84.2 977 391 2794.926
(a) (b)
Figure 2: *e optimized geometries of bioactive substances (a) crocin and (b) gallic acid.
Table 2: Encapsulation efficiency and loading capacity of calcium alginate microcapsules.
Alginate weight (w/v) (%)
Gallic acid Crocin
EE (%)a LC (g BS/100 g capsules)a EE (%)a LC (g BS/100 g capsules)a
3 41 3.76 64.11 13.98
4 41.40 3.52 64.34 11.01
5 42.92 3.22 65.10 10.09
6 43.10 2.81 66.30 8.93
aAll the data are presented as the mean of three replications.
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3.4. XRD Analysis. *e diffractograms in Figure 5 show the
XRD patterns of sodium alginate powder (Na-Alg), calcium
alginate microcapsules (Alg-3%, w/v), and calcium alginate
microcapsules (Alg-5%, w/v). XRD analysis is performed to
study the purity, phase formation, and structural properties
of the elaborated formulations. As shown in Figure 5, the
XRD spectrum of the sodium alginate (Na-Alg) indicates an
amorphous polymeric structure with a low crystallinity
observed by broads peaks at 2θ�13.8° and 21.9°. Also, the
obtained microcapsules for different alginate polymer
concentrations are amorphous in nature when compared to
the sodium alginate pattern. *ese results are supported by
previous studies, which mentioned that the calcium ion
crosslinked to the polymeric chains reduces the crystallinity
of the elaborated material [34–37].
3.5. Morphological Characterization. Scanning electron
microscopy (SEM) analysis was used to investigate the ex-
ternal morphology of the elaborated calcium alginate mi-
crocapsules.*e collectedmicrographs presented in Figure 6
show that the blank calcium alginate microcapsules (Alg-3%,
w/v) (Figure 6(a)) appeared with a spherical, smooth, and
homogenized surface due to the higher density of cross-
linked polymer matrices at the surface and inside of the
microcapsules.*emicroparticles are regularly sized around
941.8 μm.
*e calcium alginate microparticles loaded with gallic
acid (Alg-3%, w/v) (Figure 6(b)) appeared spherical with a
wrinkled surface and uniformly sized microcapsules along
with a regular surface texture. In high magnification, a
regular alignment of “lines” appears on the surface



























Figure 3: ATR-FTIR spectra of (a) gallic acid, (b) sodium alginate polymer, (c) blank calcium alginate microcapsules, (d) calcium alginate
microcapsules loaded gallic (Alg-3%), (e) calcium alginate microcapsules loaded gallic (Alg-4%), (f ) calcium alginate microcapsules loaded
gallic (Alg-5%), and (g) calcium alginate microcapsules loaded gallic (Alg-6%).



























Figure 4: ATR-FTIR spectra of (a) crocin, (b) sodium alginate polymer, (c) blank calcium alginate microcapsules, (d) calcium alginate
microcapsules loaded crocin (Alg-3%), (e) calcium alginate microcapsules loaded crocin (Alg-4%), (f ) calcium alginate microcapsules
loaded crocin (Alg-5%), and (g) calcium alginate microcapsules loaded crocin (Alg-6%).
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Figure 5: XRD patterns of sodium alginate (Na-Alg) and calcium alginate microcapsules loaded gallic acid: Alg-3% and Alg-5%.
1 mm 500 µm 300 µm
(a)
1 mm 500 µm 300 µm
(b)
1 mm 500 µm 300 µm
(c)
Figure 6: SEM photographs of blank calcium alginate microcapsules Alg-3% (a) and calcium alginate microcapsules loaded gallic acid
(b) Alg-3% and (c) Alg-5%.
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corresponding to the polymer chains; this is due to the low
density of crosslinked polymer matrices in 3% (w/v) mi-
crocapsules, resulting from the incorporation of gallic acid
molecules and, consequently, a decrease on calcium ions
inside the capsules. On the other hand, the microcapsules
loaded with gallic acid obtained from 5% (w/v) alginate
solution have a smoother surface compared to the 3% (w/v)
microcapsules (Figure 6(c)) due to the higher density of
crosslinked polymer matrices at the surface and inside of the
capsules.
3.6.ReleaseStudyofBioactiveSubstances. Figure 7 represents
the kinetics release of the bioactive substances from calcium
alginate microcapsules elaborated for various concentrations
of sodium alginate in distilled water at 25°C. In the release
profile graphs, two stages can be distinguished for all studied
systems.
*e first stage showed that an initial fast BS release
reached 85% of gallic acid during the first 20 minutes
(Figure 7(a)) and 75% during the 50 minutes for crocin
(Figure 7(b)), which can be attributed to the appearance of
bioactive substance (BS) on the surface of the microcapsules
or close to it (superficial BS). Similar results have been
reported [8, 38]. Generally, calcium alginate microparticles
encapsulate hydrophilic substance or water extracts usually
have a fast release behavior due to their porous structure
which allows the release. In this level of release, the mi-
crocapsule does not act like a barrier to prevent the en-
capsulated compound from being released [39, 40]. In the
second stage, the release was characterized by a lower and
progressive release rate of the encapsulated bioactive sub-
stance. *is step was attributed to the release of the en-
capsulated bioactive substance from the core of calcium
alginate microcapsules [8]. At this phase of release, the
microcapsules have a higher stability (the erosion of the
polymer matrix was not observed), which could be explained
by the short time of the release study and the environmental
conditions of the release medium.
*e effect of sodium alginate concentration on the ki-
netics release of bioactive substances was not observed,
which is explained by the gelling property of the polymer [8].
Generally, an increase of sodium alginate concentration
leads to introduce higher levels of Ca2+ ions. Hence, the
formulation of a dense and cohesive calcium alginate net-
work. As shown in our previous work [8], sodium alginate
polymer concentration lower than 3% has no effect on the
porosity of the microcapsules for the molecules with the
same size and physicochemical property as gallic acid
molecules; the similar results have been obtained in this
work for sodium alginate concentrations, which varies be-
tween 3 and 6% (w/v). *is leads us to conclude that the
pores volume of calcium alginate matrix is higher than the
molecular volume of gallic acid (total release rate reached
99%); similar results have been reported [8, 41].
As shown in Figures 8(a)–8(d), the structure of bio-
active substance showed some effect on the kinetics release
for all obtained formulations; this effect was observed
during the release of the encapsulated bioactive substance
in the core of the capsules, which is explained by the slow
diffusion inside the capsule. *e total release rate of gallic
acid reached 99% of the encapsulated amount, while for the
crocin molecule, the total release rate reached only 80% of
the encapsulated BS amount during 300 minutes for all
obtained formulations (Figures 8(a)–8(d)). As presented in
Table 1, the crocin molecule is more polar than the gallic
acid molecule, which explains the prolonged release of the
crocin located on the surface of calcium alginate micro-
capsules or near to the surface (superficial crocin). *is
difference on the release rate is mostly due to a strong
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Figure 7: Effect of sodium alginate concentration on the kinetics release of the gallic acid (a) and crocin (b) from calcium alginate
microcapsules in distilled water at pH� 6.8.
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interaction between crocin molecules and polymeric
chains, whereas the gallic acid molecules exhibit a less
interaction force with the microcapsule network. Fur-
thermore, the molecular volume of crocin is higher than
gallic acid, which clearly explains the limitation of the
encapsulated crocin release inside calcium alginate mi-
crocapsules. Moreover, we can assume that the pores size of
the calcium alginate network is smaller than the volume of
crocin molecules. *erefore, the release of the total en-
capsulated crocin amount needs specific conditions in
order to break the calcium alginate network (erosion
conditions). Another explanation for the release limitations
of crocin is the reticulation between polymeric chains of
alginate and crocin molecules due to their ramified
structure. *e delivery system in this case needs a large
period of time to allow the diffusion of crocin molecules
through the polymeric network. So, for the same micro-
capsules system, the release mechanism is affected by the
structure and physicochemical properties of the encapsu-
lated molecules; similar results have been reported [42–45].
*e kinetics of gallic acid and crocin release were
assessed using a variety of mathematical models, including
zero-order, first-order, and Korsmeyer–Peppas kinetic
models. Using OriginPro 2018 software, the squared cor-
relation coefficient (R2) values of these models were obtained
in order to assess their prediction capacity and accuracy
(Figure 9 and Table 3).
Based on the correlation coefficients (R2), the zero-order
and first-order are the worst models. *erefore, the best one
was the Korsmeyer–Peppas model, and consequently, the
release kinetics of gallic acid and crocin follow the Kors-
meyer–Peppas model.












































































































Figure 8: Effect of bioactive substance characteristics on the kinetics release from calcium alginate microcapsules with different sodium
alginate concentrations in distilled water at pH� 6.8. (a) Alg-3%; (b) Alg-4%; (c) Alg-5%; (d) Alg-6%.
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Figure 9: *e fitting of active substance release data to zero-order (a), first-order (b), and Korsmeyer–Peppas (c) kinetic models of the
selected sodium alginate concentrations.





R2 k0 R2 k1 R2 kp n
3 0.86855 0.09784 0.81579 0.04676 0.96247 0.4318 0.30188
4 0.95392 0.10101 0.92579 0.04204 0.99803 0.4851 0.25945
5 0.92556 0.09082 0.88123 0.05574 0.98956 0.3739 0.35106
6 0.91368 0.10031 0.86145 0.05143 0.98265 0.4098 0.32647
Microcapsules code (%) CrocinR2 k0 R2 k1 R2 kp n
3 0.94678 0.00483 0.89886 0.04146 0.99847 0.2550 0.32176
4 0.95284 0.00415 0.90463 0.03984 0.99883 0.2507 0.30818
5 0.95463 0.00473 0.04497 0.04497 0.99896 0.2282 0.34832
6 0.96084 0.00441 0.90734 0.04995 0.9992 0.2027 0.38595
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For all formulation studies, the obtained n values (Ta-
ble 3) are around 0.310± 0.033 for gallic acid and
0.341± 0.029 for crocin, suggesting that the diffusion process
of the bioactive substances from the Ca-alginate micro-
capsules is a Fickian type. Similar results have been found in
several reported works: our study about gallic acid release
from calcium alginate microcapsules with different sizes [8],
the release of cinnamon essential oil encapsulated in alginate
beads by Paris et al. [46], and the kinetic release of Tri-
choderma viride spores loaded calcium alginate micro-
spheres by Jurić et al. [47]. Our results help out to further
understand the release mechanisms of phenolic and flavo-
noid substances such as gallic acid and crocin from Ca-
alginate microcapsules throughout the storage and their use
in functional applications.
4. Conclusion
As part of the ongoing work, a bioactive substance delivery
system based on the calcium alginate network was suc-
cessfully prepared by the ionotropic gelation method using
different concentrations of alginate polymer followed by
their physicochemical characterization. Increasing the al-
ginate polymer concentration increases the efficiency of the
encapsulation and decreases the carrying capacity. *e
structure and physicochemical characteristics of the bio-
active substance showed a significant effect on the im-
provement of EE and LC. *e ATR-FTIR result confirmed
the incorporation of bioactive substances such as gallic acid
and crocin in the microcapsules, with a possibility of in-
teraction with the calcium alginate matrix. XRD analysis
showed that the low crystallinity observed at sodium alginate
polymer disappears when the calcium alginate microcapsule
was elaborated. *e SEM result showed that the obtained
microparticles appeared spherical with a wrinkled surface
and a uniform texture.
*e release study of gallic acid and crocin as bioactive
substances in distilled water (as a hydrophilic system) at pH
value 6.8 showed that the bioactive substances released from
microcapsules have fast kinetics release (85% within the first
20 minutes for gallic acid and 75% within the 50 minutes for
crocin) with no observed effect of alginate polymer con-
centration on the release kinetics. Whereas the structure and
the physical-chemical properties of the bioactive substance
showed a clear effect on the kinetics release for all obtained
formulations, this effect could be observed during the release
of the encapsulated compounds located in the core of the Ca-
alginate microcapsules. *e fitting of the bioactive sub-
stances release data to zero-order and first-order, and
Korsmeyer–Peppas mathematical models indicates that the
diffusion process of the bioactive substances from calcium
alginate microcapsules is a Fickian type.
*e obtained results suggest that alginate microparticles
elaborated by the ionotropic gelling method are a promising
system to encapsulate and control the release of water-
soluble phenolic and flavonoid compounds such as gallic
acid and crocin in order to further increase their applications
in functional formulations.
In our future studies, there is a vision to study the effect
of polymer structure, polymer-drug ratio, and other pa-
rameters on the encapsulation efficiency, loading capacity,
release profile, and mechanical property for the simple and
hybrid systems (polymer-clay).
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“Characterization of alginate beads with encapsulated cocoa
extract to prepare functional food: comparison of two gelation
mechanisms,” Food Hydrocolloids, vol. 49, pp. 25–34, 2015.
[41] M. Hu, G. Zheng, D. Zhao, and W. Yu, “Characterization of
the structure and diffusion behavior of calcium alginate gel
beads,” Journal of Applied Polymer Science, vol. 137, pp. 1–9,
2020.
[42] J. M. C. Puguan, X. Yu, and H. Kim, “Diffusion characteristics
of different molecular weight solutes in Ca-alginate gel beads,”
Colloids and Surfaces A: Physicochemical and Engineering
Aspects, vol. 469, pp. 158–165, 2015.
[43] Q. Pan, X. Deng, W. Gao, J. Chang, Y. Pu, and B. He, “Small
molecules-PEG amphiphilic conjugates as carriers for drug
delivery: 1. the effect of molecular structures on drug en-
capsulation,” Journal of Drug Delivery Science and Technology,
vol. 60, Article ID 101997, 2020.
[44] L. Rolland, E. Santanach-Carreras, T. Delmas, J. Bibette, and
N. Bremond, “Physicochemical properties of aqueous core
hydrogel capsules,” Soft Matter, vol. 10, no. 48, pp. 9668–9674,
2014.
[45] G. S. Offeddu, E. Axpe, B. A. C. Harley, and M. L. Oyen,
“Relationship between permeability and diffusivity in poly-
ethylene glycol hydrogels,” AIP Advances, vol. 8, Article ID
105006, 2018.
[46] M. J. Paris, N. Ramı́rez-Corona, E. Palou, and A. López-Malo,
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